{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:03:06Z","timestamp":1787785386953,"version":"build-2784847793"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s13555-026-01703-3","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T13:34:41Z","timestamp":1772544881000},"page":"2047-2061","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Psychiatric and Psychological Approach in Patients with Atopic Dermatitis, Hidradenitis Suppurativa and Psoriasis: A Propensity-Matched Real-World Cohort Study"],"prefix":"10.1007","volume":"16","author":[{"given":"Marta","family":"Szepietowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr K.","family":"Krajewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemyslaw","family":"Pacan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wojas-Pelc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0766-6342","authenticated-orcid":false,"given":"Jacek C.","family":"Szepietowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej K.","family":"Jaworek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"issue":"e239\u2013242","key":"1703_CR1","doi-asserted-by":"publisher","first-page":"20120523","DOI":"10.1111\/j.1468-3083.2012.04578.x","volume":"27","author":"D Chrostowska-Plak","year":"2013","unstructured":"Chrostowska-Plak D, Reich A, Szepietowski JC. Relationship between itch and psychological status of patients with atopic dermatitis. J Eur Acad Dermatol Venereol. 2013;27(e239\u2013242):20120523. https:\/\/doi.org\/10.1111\/j.1468-3083.2012.04578.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1703_CR2","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/wps.21110","volume":"22","author":"M Berk","year":"2023","unstructured":"Berk M, Kohler-Forsberg O, Turner M, et\u00a0al. Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management. World Psychiatry. 2023;22:366\u201387. https:\/\/doi.org\/10.1002\/wps.21110.","journal-title":"World Psychiatry"},{"issue":"984\u2013991","key":"1703_CR3","doi-asserted-by":"publisher","first-page":"20141218","DOI":"10.1038\/jid.2014.530","volume":"135","author":"FJ Dalgard","year":"2015","unstructured":"Dalgard FJ, Gieler U, Tomas-Aragones L, et\u00a0al. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Investig Dermatol. 2015;135(984\u2013991):20141218. https:\/\/doi.org\/10.1038\/jid.2014.530.","journal-title":"J Investig Dermatol"},{"issue":"406\u2013412","key":"1703_CR4","doi-asserted-by":"publisher","first-page":"20180221","DOI":"10.1111\/cod.12973","volume":"78","author":"SE Marron","year":"2018","unstructured":"Marron SE, Tomas-Aragones L, Navarro-Lopez J, et\u00a0al. The psychosocial burden of hand eczema: data from a European dermatological multicentre study. Contact Dermat. 2018;78(406\u2013412):20180221. https:\/\/doi.org\/10.1111\/cod.12973.","journal-title":"Contact Dermat"},{"key":"1703_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-025-04269-w","volume":"317","author":"Y Yang","year":"2025","unstructured":"Yang Y, Li JX, Wang ZL, et\u00a0al. A comprehensive bibliometric analysis of the association between atopic dermatitis and depression (1994-2024). Arch Dermatol Res. 2025;317:771. https:\/\/doi.org\/10.1007\/s00403-025-04269-w.","journal-title":"Arch Dermatol Res"},{"key":"1703_CR6","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1038\/d41586-025-02646-z","volume":"644","author":"A Keener","year":"2025","unstructured":"Keener A. Explaining the mental-health burden of atopic dermatitis. Nature. 2025;644:S6\u20138. https:\/\/doi.org\/10.1038\/d41586-025-02646-z.","journal-title":"Nature"},{"key":"1703_CR7","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.2340\/00015555-2760","volume":"97","author":"K Lesner","year":"2017","unstructured":"Lesner K, Reich A, Szepietowski JC, et\u00a0al. Determinants of psychosocial health in psoriatic patients: a multi-national study. Acta Derm Venereol. 2017;97:1182\u20138. https:\/\/doi.org\/10.2340\/00015555-2760.","journal-title":"Acta Derm Venereol"},{"key":"1703_CR8","doi-asserted-by":"publisher","first-page":"264","DOI":"10.2340\/00015555-0866","volume":"90","author":"L Matusiak","year":"2010","unstructured":"Matusiak L, Bieniek A, Szepietowski JC. Psychophysical aspects of hidradenitis suppurativa. Acta Derm Venereol. 2010;90:264\u20138. https:\/\/doi.org\/10.2340\/00015555-0866.","journal-title":"Acta Derm Venereol"},{"issue":"35\u201339","key":"1703_CR9","doi-asserted-by":"publisher","first-page":"20220829","DOI":"10.5114\/ada.2022.119080","volume":"40","author":"JE Rymaszewska","year":"2023","unstructured":"Rymaszewska JE, Krajewski PK, Szczech J, et\u00a0al. Depression and anxiety in hidradenitis suppurativa patients: a cross-sectional study among Polish patients. Postepy Dermatol Alergol. 2023;40(35\u201339):20220829. https:\/\/doi.org\/10.5114\/ada.2022.119080.","journal-title":"Postepy Dermatol Alergol"},{"issue":"1537\u20131566","key":"1703_CR10","doi-asserted-by":"publisher","first-page":"20250502","DOI":"10.1111\/jdv.20639","volume":"39","author":"A Wollenberg","year":"2025","unstructured":"Wollenberg A, Kinberger M, Arents B, et\u00a0al. European guideline (EuroGuiDerm) on atopic eczema: living update. J Eur Acad Dermatol Venereol. 2025;39(1537\u20131566):20250502. https:\/\/doi.org\/10.1111\/jdv.20639.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1703_CR11","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1037\/0022-006x.63.4.624","volume":"63","author":"A Ehlers","year":"1995","unstructured":"Ehlers A, Stangier U, Gieler U. Treatment of atopic dermatitis: a comparison of psychological and dermatological approaches to relapse prevention. J Consult Clin Psychol. 1995;63:624\u201335. https:\/\/doi.org\/10.1037\/0022-006x.63.4.624.","journal-title":"J Consult Clin Psychol"},{"key":"1703_CR12","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.jaci.2017.01.029","volume":"140","author":"A Heratizadeh","year":"2017","unstructured":"Heratizadeh A, Werfel T, Wollenberg A, et\u00a0al. Effects of structured patient education in adults with atopic dermatitis: multicenter randomized controlled trial. J Allergy Clin Immunol. 2017;140:845-853e843. https:\/\/doi.org\/10.1016\/j.jaci.2017.01.029.","journal-title":"J Allergy Clin Immunol"},{"key":"1703_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.24869\/psyd.2024.7","volume":"36","author":"K Krstanovic","year":"2024","unstructured":"Krstanovic K, Kroflin K, Kroflin L, et\u00a0al. Psoriasis and mental health: a psychodermatological approach with an emphasis on psychotherapy. Psychiatr Danub. 2024;36:7\u201316. https:\/\/doi.org\/10.24869\/psyd.2024.7.","journal-title":"Psychiatr Danub"},{"key":"1703_CR14","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2024.2427321","volume":"36","author":"L Lu","year":"2025","unstructured":"Lu L, Xu Y, Shi M, et\u00a0al. Psychosocial interventions for psoriasis: a Bayesian network meta-analysis. J Dermatol Treat. 2025;36:2427321. https:\/\/doi.org\/10.1080\/09546634.2024.2427321.","journal-title":"J Dermatol Treat"},{"key":"1703_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.12788\/cutis.0195","volume":"107","author":"A Misitzis","year":"2021","unstructured":"Misitzis A, Katoulis A. Assessing psychological interventions for hidradenitis suppurativa as a first step toward patient-centered practice. Cutis. 2021;107:123\u20134. https:\/\/doi.org\/10.12788\/cutis.0195.","journal-title":"Cutis"},{"key":"1703_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2340\/00015555-1415","volume":"93","author":"C Schut","year":"2013","unstructured":"Schut C, Weik U, Tews N, et\u00a0al. Psychophysiological effects of stress management in patients with atopic dermatitis: a randomized controlled trial. Acta Derm Venereol. 2013;93:57\u201361. https:\/\/doi.org\/10.2340\/00015555-1415.","journal-title":"Acta Derm Venereol"},{"key":"1703_CR17","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.2147\/JMDH.S324325","volume":"14","author":"E Tarca","year":"2021","unstructured":"Tarca E, Cojocaru E, Caba B, et\u00a0al. Multidisciplinary management of adolescents with hidradenitis suppurativa \u2013 Series of cases and literature review. J Multidiscip Healthc. 2021;14:2205\u201316. https:\/\/doi.org\/10.2147\/JMDH.S324325.","journal-title":"J Multidiscip Healthc"},{"key":"1703_CR18","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, et\u00a0al. Psoriasis. Lancet. 2021;397:1301\u201315. https:\/\/doi.org\/10.1016\/S0140-6736(20)32549-6.","journal-title":"Lancet"},{"key":"1703_CR19","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S0140-6736(24)02475-9","volume":"405","author":"R Sabat","year":"2025","unstructured":"Sabat R, Alavi A, Wolk K, et\u00a0al. Hidradenitis suppurativa. Lancet. 2025;405:420\u201338. https:\/\/doi.org\/10.1016\/S0140-6736(24)02475-9.","journal-title":"Lancet"},{"key":"1703_CR20","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra2023911","volume":"384","author":"S Stander","year":"2021","unstructured":"Stander S. Atopic dermatitis. N Engl J Med. 2021;384:1136\u201343. https:\/\/doi.org\/10.1056\/NEJMra2023911.","journal-title":"N Engl J Med"},{"key":"1703_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2025.10.022","author":"KR Chan","year":"2025","unstructured":"Chan KR, Keddie SH, Flohr C, et\u00a0al. Prevalence of atopic dermatitis in the United States from 2021\u20132024: data from the National Health Interview Survey. J Am Acad Dermatol. 2025. https:\/\/doi.org\/10.1016\/j.jaad.2025.10.022.","journal-title":"J Am Acad Dermatol"},{"key":"1703_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/bjd\/ljad339","volume":"190","author":"J Tian","year":"2023","unstructured":"Tian J, Zhang D, Yang Y, et\u00a0al. Global epidemiology of atopic dermatitis: a comprehensive systematic analysis and modelling study. Br J Dermatol. 2023;190:55\u201361. https:\/\/doi.org\/10.1093\/bjd\/ljad339.","journal-title":"Br J Dermatol"},{"key":"1703_CR23","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1001\/jamadermatol.2025.2373","volume":"161","author":"D Bouazzi","year":"2025","unstructured":"Bouazzi D, Nielsen SM, Hagan PG, et\u00a0al. Prevalence of hidradenitis suppurativa: a meta-analysis of global hidradenitis suppurativa atlas studies. JAMA Dermatol. 2025;161:1022\u20138. https:\/\/doi.org\/10.1001\/jamadermatol.2025.2373.","journal-title":"JAMA Dermatol"},{"key":"1703_CR24","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000541951","volume":"241","author":"K Knecht-Gurwin","year":"2025","unstructured":"Knecht-Gurwin K, Gurwin A, Wrobel T, et\u00a0al. Prevalence of hidradenitis suppurativa in Poland. Dermatology. 2025;241:98\u2013106. https:\/\/doi.org\/10.1159\/000541951.","journal-title":"Dermatology"},{"issue":"3","key":"1703_CR25","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.pop.2025.05.007","volume":"52","author":"MF Helm","year":"2025","unstructured":"Helm MF, Clebak KT, Critchfield L, et\u00a0al. Psoriasis and papulosquamous disorders. Prim Care. 2025;52(3):567\u201391. https:\/\/doi.org\/10.1016\/j.pop.2025.05.007.","journal-title":"Prim Care"},{"key":"1703_CR26","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2340\/00015555-0676","volume":"89","author":"D Chrostowska-Plak","year":"2009","unstructured":"Chrostowska-Plak D, Salomon J, Reich A, et\u00a0al. Clinical aspects of itch in adult atopic dermatitis patients. Acta Derm Venereol. 2009;89:379\u201383. https:\/\/doi.org\/10.2340\/00015555-0676.","journal-title":"Acta Derm Venereol"},{"key":"1703_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11133813","author":"P Agarwal","year":"2022","unstructured":"Agarwal P, Lunge SB, Shetty NS, et\u00a0al. Itch in hidradenitis suppurativa\/acne inversa: a systematic review. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11133813.","journal-title":"J Clin Med"},{"key":"1703_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2340\/00015555-2815","volume":"98","author":"L Matusiak","year":"2018","unstructured":"Matusiak L, Szczech J, Kaaz K, et\u00a0al. Clinical characteristics of pruritus and pain in patients with hidradenitis suppurativa. Acta Derm Venereol. 2018;98:191\u20134. https:\/\/doi.org\/10.2340\/00015555-2815.","journal-title":"Acta Derm Venereol"},{"key":"1703_CR29","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/jdv.18850","volume":"37","author":"K Jaworecka","year":"2023","unstructured":"Jaworecka K, Kwiatkowska D, Marek-Jozefowicz L, et\u00a0al. Characteristics of pruritus in various clinical variants of psoriasis: final report of the binational, multicentre, cross-sectional study. J Eur Acad Dermatol Venereol. 2023;37:787\u201395. https:\/\/doi.org\/10.1111\/jdv.18850.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1703_CR30","volume-title":"Itch: mechanisms and treatment","author":"A Reich","year":"2014","unstructured":"Reich A, Szepietowski JC. Clinical aspects of itch: psoriasis. In: Carstens E, Akiyama T, editors. Itch: mechanisms and treatment. Boca Raton: CRC Press; 2014."},{"key":"1703_CR31","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2340\/00015555-3147","volume":"99","author":"R Reszke","year":"2019","unstructured":"Reszke R, Bialynicki-Birula R, Szepietowski JC. Itch in psoriasis: a new look at well-known subject. Acta Derm Venereol. 2019;99:429\u201334. https:\/\/doi.org\/10.2340\/00015555-3147.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"1703_CR32","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3724","volume":"101","author":"PK Krajewski","year":"2021","unstructured":"Krajewski PK, Matusiak L, von Stebut E, et\u00a0al. Pain in hidradenitis suppurativa: a cross-sectional study of 1795 patients. Acta Derm Venereol. 2021;101(1):adv00364. https:\/\/doi.org\/10.2340\/00015555-3724.","journal-title":"Acta Derm Venereol"},{"key":"1703_CR33","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1016\/j.jaad.2024.09.006","volume":"91","author":"V Surapaneni","year":"2024","unstructured":"Surapaneni V, Milosavljevic MV, Orenstein LAV. Pain management in hidradenitis suppurativa. J Am Acad Dermatol. 2024;91:S52\u201363. https:\/\/doi.org\/10.1016\/j.jaad.2024.09.006.","journal-title":"J Am Acad Dermatol"},{"key":"1703_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13123610","author":"M Kotewicz","year":"2024","unstructured":"Kotewicz M, Krajewski PK, Jaworek AK, et\u00a0al. Clinical characteristics of cutaneous pain in psoriasis. J Clin Med. 2024. https:\/\/doi.org\/10.3390\/jcm13123610.","journal-title":"J Clin Med"},{"key":"1703_CR35","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3617","volume":"100","author":"M Pojawa-Golab","year":"2020","unstructured":"Pojawa-Golab M, Reich A. Skin pain in patients with atopic dermatitis or psoriasis: a web-based survey. Acta Derm Venereol. 2020;100:adv00258. https:\/\/doi.org\/10.2340\/00015555-3617.","journal-title":"Acta Derm Venereol"},{"key":"1703_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13164890","author":"M Kotewicz","year":"2024","unstructured":"Kotewicz M, Krajewski PK, Jaworek AK, et\u00a0al. Psychological aspects of cutaneous pain in psoriasis. J Clin Med. 2024. https:\/\/doi.org\/10.3390\/jcm13164890.","journal-title":"J Clin Med"},{"issue":"1","key":"1703_CR37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5114\/ada.2024.143787","volume":"42","author":"MM Kotewicz","year":"2025","unstructured":"Kotewicz MM, Krajewski PK, Jaworek AK, et\u00a0al. Psoriatic itch from the patients\u2019 perspective: a cross-sectional study. Postepy Dermatol Alergol. 2025;42(1):21\u20137. https:\/\/doi.org\/10.5114\/ada.2024.143787.","journal-title":"Postepy Dermatol Alergol"},{"key":"1703_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/life11010034","author":"PK Krajewski","year":"2021","unstructured":"Krajewski PK, Matusiak L, von Stebut E, et\u00a0al. Quality-of-life impairment among patients with hidradenitis suppurativa: a cross-sectional study of 1795 patients. Life (Basel). 2021. https:\/\/doi.org\/10.3390\/life11010034.","journal-title":"Life (Basel)"},{"key":"1703_CR39","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1111\/jdv.19913","volume":"38","author":"C Zeidler","year":"2024","unstructured":"Zeidler C, Kupfer J, Dalgard FJ, et\u00a0al. Dermatological patients with itch report more stress, stigmatization experience, anxiety and depression compared to patients without itch: results from a European multi-centre study. J Eur Acad Dermatol Venereol. 2024;38:1649\u201361. https:\/\/doi.org\/10.1111\/jdv.19913.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"1703_CR40","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.jid.2019.05.034","volume":"140","author":"FJ Dalgard","year":"2020","unstructured":"Dalgard FJ, Svensson A, Halvorsen JA, et\u00a0al. Itch and mental health in dermatological patients across Europe: a cross-sectional study in 13 countries. J Investig Dermatol. 2020;140(3):568\u201373. https:\/\/doi.org\/10.1016\/j.jid.2019.05.034.","journal-title":"J Investig Dermatol"},{"key":"1703_CR41","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1111\/ddg.14507","volume":"19","author":"A Nast","year":"2021","unstructured":"Nast A, Altenburg A, Augustin M, et\u00a0al. German S3-Guideline on the treatment of psoriasis vulgaris, adapted from EuroGuiDerm \u2013 part 2: treatment monitoring and specific clinical or comorbid situations. J Dtsch Dermatol Ges. 2021;19:1092\u2013115. https:\/\/doi.org\/10.1111\/ddg.14507.","journal-title":"J Dtsch Dermatol Ges"},{"key":"1703_CR42","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1111\/ddg.14508","volume":"19","author":"A Nast","year":"2021","unstructured":"Nast A, Altenburg A, Augustin M, et\u00a0al. German S3-Guideline on the treatment of psoriasis vulgaris, adapted from EuroGuiDerm \u2013 part 1: treatment goals and treatment recommendations. JDDG J Dtsch Dermatol Ges. 2021;19:934\u2013150. https:\/\/doi.org\/10.1111\/ddg.14508.","journal-title":"JDDG J Dtsch Dermatol Ges"},{"key":"1703_CR43","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/jdv.20472","volume":"39","author":"CC Zouboulis","year":"2025","unstructured":"Zouboulis CC, Bechara FG, Benhadou F, et\u00a0al. European S2k guidelines for hidradenitis suppurativa\/acne inversa part 2: treatment. J Eur Acad Dermatol Venereol. 2025;39:899\u2013941. https:\/\/doi.org\/10.1111\/jdv.20472.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1703_CR44","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005411","volume":"95","author":"J Shin","year":"2016","unstructured":"Shin J, Choi Y, Park EC, et\u00a0al. Psychiatry outpatient visits by atopic dermatitis patients varying in the complexity of their prescriptions: a nationwide cohort study conducted from 2005 to 2013. Medicine (Baltimore). 2016;95:e5411. https:\/\/doi.org\/10.1097\/MD.0000000000005411.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1703_CR45","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/bjd.19817","volume":"185","author":"I Vittrup","year":"2021","unstructured":"Vittrup I, Andersen YMF, Droitcourt C, et\u00a0al. Association between hospital-diagnosed atopic dermatitis and psychiatric disorders and medication use in childhood. Br J Dermatol. 2021;185(1):91\u2013100. https:\/\/doi.org\/10.1111\/bjd.19817.","journal-title":"Br J Dermatol"},{"issue":"1","key":"1703_CR46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s13555-020-00459-8","volume":"11","author":"G Girolomoni","year":"2021","unstructured":"Girolomoni G, Luger T, Nosbaum A, et\u00a0al. The economic and psychosocial comorbidity burden among adults with moderate-to-severe atopic dermatitis in Europe: analysis of a cross-sectional survey. Dermatol Ther (Heidelb). 2021;11(1):117\u201330. https:\/\/doi.org\/10.1007\/s13555-020-00459-8.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1703_CR47","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1177\/12034754221117736","volume":"26","author":"W Badaiki","year":"2022","unstructured":"Badaiki W, Penney M, Pyper E, et\u00a0al. Real world studies of Psoriasis and mental illness in Newfoundland and Labrador. J Cutan Med Surg. 2022;26:494\u2013501. https:\/\/doi.org\/10.1177\/12034754221117736.","journal-title":"J Cutan Med Surg"},{"key":"1703_CR48","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1111\/ijd.14130","volume":"57","author":"G Shalom","year":"2018","unstructured":"Shalom G, Zisman D, Babaev M, et\u00a0al. Psoriasis in Israel: demographic, epidemiology, and healthcare services utilization. Int J Dermatol. 2018;57:1068\u201374. https:\/\/doi.org\/10.1111\/ijd.14130.","journal-title":"Int J Dermatol"},{"key":"1703_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10184194","author":"A Glowaczewska","year":"2021","unstructured":"Glowaczewska A, Reszke R, Szepietowski JC, et\u00a0al. Indirect self-destructiveness in hidradenitis suppurativa patients. J Clin Med. 2021. https:\/\/doi.org\/10.3390\/jcm10184194.","journal-title":"J Clin Med"},{"key":"1703_CR50","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0140-6736(23)00022-3","volume":"401","author":"AB Kimball","year":"2023","unstructured":"Kimball AB, Jemec GBE, Alavi A, et\u00a0al. Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials. Lancet. 2023;401:747\u201361. https:\/\/doi.org\/10.1016\/S0140-6736(23)00022-3.","journal-title":"Lancet"},{"key":"1703_CR51","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1016\/S0140-6736(24)00101-6","volume":"403","author":"AB Kimball","year":"2024","unstructured":"Kimball AB, Jemec GBE, Sayed CJ, et\u00a0al. Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials. Lancet. 2024;403:2504\u201319. https:\/\/doi.org\/10.1016\/S0140-6736(24)00101-6.","journal-title":"Lancet"},{"key":"1703_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-025-01550-8","author":"G Avallone","year":"2025","unstructured":"Avallone G, Bombelli A, Gargiulo L, et\u00a0al. Effectiveness, safety, and health-related quality of life in moderate-to-severe atopic dermatitis treated with lebrikizumab: a 16-week nationwide retrospective cohort study. Dermatol Ther Heidelb. 2025. https:\/\/doi.org\/10.1007\/s13555-025-01550-8.","journal-title":"Dermatol Ther Heidelb"},{"issue":"9","key":"1703_CR53","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1111\/1346-8138.17866","volume":"52","author":"S Gerdes","year":"2025","unstructured":"Gerdes S, Weisenseel P, Gross D, et\u00a0al. Long-term impact of Guselkumab on skin, sexuality, and perceived stigmatization in patients with psoriasis in routine clinical practice: week 76 effectiveness and safety results from the prospective German Multicenter G-EPOSS Study. J Dermatol. 2025;52(9):1368\u201381. https:\/\/doi.org\/10.1111\/1346-8138.17866.","journal-title":"J Dermatol"},{"key":"1703_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13061602","author":"A Courtney","year":"2024","unstructured":"Courtney A, Su JC. The psychology of atopic dermatitis. J Clin Med. 2024. https:\/\/doi.org\/10.3390\/jcm13061602.","journal-title":"J Clin Med"},{"key":"1703_CR55","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1007\/s13555-023-01060-5","volume":"13","author":"PC Luna","year":"2023","unstructured":"Luna PC, Chu CY, Fatani M, et\u00a0al. Psychosocial burden of psoriasis: a systematic literature review of depression among patients with psoriasis. Dermatol Ther (Heidelb). 2023;13:3043\u201355. https:\/\/doi.org\/10.1007\/s13555-023-01060-5.","journal-title":"Dermatol Ther (Heidelb)"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01703-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01703-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01703-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T03:38:43Z","timestamp":1775101123000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-026-01703-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1703"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01703-3","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The following authors: Marta Szepietowska, Piotr K Krajewski, Przemyslaw Pacan, Anna Wojas-Pelc and Andrzej K Jaworek declared no potential conflicts of interest with respect to the research, authorship, and publication of this article. Jacek C. Szepietowski is an Editorial Board member of\n                      Dermatology and Therapy\n                      . Jacek C. Szepietowski was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"As all information accessed for this study was deidentified within the TriNetX platform, institutional review board (IRB) approval and informed consent were not required. The access for the TriNetX platform was obtained by Dr Piotr K. Krajewski who works as a guest scientist at the University of L\u00fcbeck. No additional permissions were required. The study adheres to ethical guidelines for the secondary use of anonymized patient data and complies with all relevant data protection and research integrity standards. All patient data in the TriNetX database is certified as anonymized under Section \u00a7164.514(a) and \u00a7164.514(b)(1) of the HIPAA Privacy Rule and, when relevant, the GDPR of the European Union.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}